A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma

Auteurs

Perrine Marec-Berard, Cécile Dalban, Nathalie Gaspar, Laurence Brugieres, Jean-Claude Gentet, Cyril Lervat, Nadège Corradini, Marie-Pierre Castex, Claudine Schmitt, Hélène Pacquement, Marie-Dominique Tabone, Mehdi Brahmi, Séverine Metzger, Jean-Yves Blay, David Pérol